GlassScriptPhysician profile
Luis A Matos
NPI 1972506509
$2,373.64
in general payments reported to CMS, 2019-2025
18 companies · $269 in 2025
The $269 reported for 2025 was less than what a typical Allergy provider received nationally (typical 2025 total: $1,129).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $523 · 2020: $249 · 2021: $518 · 2022: $345 · 2023: $273 · 2024: $197 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $739.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $738.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $842.92 | 2019-2025 | Tezspire, Fasenra, Airsupra |
| Genzyme Corporation | $359.63 | 2019-2025 | |
| Glaxosmithkline, LLC. | $238.67 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genentech USA, INC. | $140.74 | 2019-2023 | Xolair |
| Novartis Pharmaceuticals Corporation | $126.21 | 2019-2020 | |
| Csl Behring | $112.03 | 2019-2023 | Hizentra |
| Blueprint Medicines Corporation | $109.84 | 2023-2025 | Ayvakit |
| Regeneron Healthcare Solutions, INC. | $106.43 | 2021-2022 | |
| Amgen INC. | $62.41 | 2021 | |
| Pfizer INC. | $56.02 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.92 | 2020-2022 | |
| Optinose US, INC. | $32.89 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $29.55 | 2021 | |
| Genentech, INC. | $29.08 | 2021 | |
| Sunovion Pharmaceuticals INC. | $26.84 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $26.38 | 2019 | |
| Mylan Specialty L.P. | $19.08 | 2020 | |
| Circassia INC. | $16.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Matos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.